CD276 and plasma cell myeloma: The cell surface expression of B7-H3 was assessed in various target cell lines, namely multiple myeloma (MM) cell lines NCI-H929, L-363, and KMS12-PE, utilizing flow cytometry and immunofluorescence assay (IFA) with the specific B7-H3 antibody (F-11).